This study is the first in Vietnam to define the pathogenic variant profile of CAH caused by mutation of CYP21A2. The results should help in further understanding the genotype‐phenotype relationship of CAH patients and guide better treatment and management of the affected fetuses/children. This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.